Isolation and characterization of a human antibody fragment specific for Ts1 toxin from Tityus serrulatus scorpion

Immunology Letters

Volumn 139, Issue 1-2, 2011, Pages 73-79

  Amaro, Itzel ^a   Riaño Umbarila, Lidia ^a   Becerril, Baltazar ^a   Possani, Lourival D ^a  

^a INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

Author keywords

Antibody; Human scFv; Phage display; Scorpion toxin; Tityus serrulatus

Indexed keywords

ANTIDOTE; SCORPION VENOM; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TS 1 TOXIN; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY ISOLATION; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; DRUG SYNTHESIS; DRUG TARGETING; INTOXICATION; LD 50; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; PHAGE DISPLAY; POISONOUS SCORPION; PRIORITY JOURNAL; PROVOCATION TEST; SCORPION; SPECIES COMPARISON; TITYUS CAMBRIDGEI; TITYUS PACKYURIS; TITYUS SERRULATUS; TOXICITY TESTING;

AMINO ACID SEQUENCE; ANIMALS; CROSS REACTIONS; EPITOPES; ESCHERICHIA COLI; HUMANS; INSECT PROTEINS; MALE; MICE; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDE LIBRARY; RECOMBINANT PROTEINS; SCORPION VENOMS; SCORPIONS; SEQUENCE ALIGNMENT; SINGLE-CHAIN ANTIBODIES;

EID: 79960699425     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.05.002     Document Type: Article

References (42)

1. Laffly E., Sodoyer R. Monoclonal antibodies 30 years of success. J Soc Biol 2006, 200:325-343.
2. Oldham R.K., Dillman R.O. Monoclonal antibodies in cancer therapy: 25 years of progress. J Clin Oncol 2008, 26:1774-1777.
3. Laffly E., Sodoyer R. Monoclonal and recombinant antibodies 30 years after. Hum Antibodies 2005, 14:33-55.
4. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256:495-497.
5. Smith G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985, 228:1315-1317.
6. Nelson A.L., Dhimolea E., Reichert J.M. Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov 2010, 9:767-774.
7. Pande J., Szewczyk M.M., Grover A.K. Phage display: concept, innovations, applications and future. Biotechnol Adv 2010, 28:849-858.
8. Ho M, Feng M., Fisher R.J., Rader C., Pastan I. A novel high-affinity human monoclonal antibody to mesothelin. Int J Cancer 2011, 128:2020-2030.
9. Lanzavecchia A., Corti D., Sallusto F. Human monoclonal antibodies by immortalization of memory B cells. Curr Opin Biotechnol 2007, 18:523-528.
10. Nelson A.L. Antibody fragments: hope and hype. MABs 2010, 2:77-83.
11. Chippaux J.P., Goyffon M. Epidemiology of scorpionism: a global appraisal. Acta Trop 2008, 107:71-79.
12. Dehesa-Davila M., Possani L.D. Scorpionism and serotherapy in Mexico. Toxicon 1994, 32:1015-1018.
13. Ministério da Saúde, Brasil. Acidentes com animais peçonhentos crescem quase 33% nos últimos seis anos; 2010. Available from: [last accessed 31.03.11]. http://portal.saude.gov.br/portal/aplicacoes/noticias/default.cfm?pg=dspDetalheNoticia&id_area=1498&CO_NOTICIA=11570.
14. Licea A.F., Becerril B., Possani L.D. Fab fragments of the monoclonal antibody BCF2 are capable of neutralizing the whole soluble venom from the scorpion Centruroides noxius Hoffmann. Toxicon 1996, 34:843-847.
15. Riaño-Umbarila L., Juárez-González V.R., Olamendi-Portugal T., Ortíz-León M., Possani L.D., Becerril B. A strategy for the generation of specific human antibodies by directed evolution and phage display. An example of a single-chain antibody fragment that neutralizes a major component of scorpion venom. FEBS J 2005, 272:2591-2601.
16. Possani L.D., Martin B.M., Mochca-Morales J., Svendsen I. Purification and chemical characterization of the major toxins from the venom of the Brazilian scorpion Tityus serrulatus Lutz and Mello. Carlsberg Res Commun 1981, 46:195-205.
17. Possani L.D., Martin B.M., Svendsen I., Rode G.S., Erickson B.W. Scorpion toxins from Centruroides noxius and Tityus serrulatus. Primary structures and sequence comparison by metric analysis. Biochem J 1985, 229:739-750.
18. Kirsch G.E., Skattebøl A., Possani L.D., Brown A.M. Modification of Na channel gating by an alpha scorpion toxin from Tityus serrulatus. J Gen Physiol 1989, 93:67-83.
19. Mendes T.M., Dias F., Horta C.C., Pena I.F., Arantes E.C., Kalapothakis E. Effective Tityus serrulatus anti-venom produced using the Ts1 component. Toxicon 2008, 52:787-793.
20. Duarte C.G., Alvarenga L.M., Dias-Lopes C., Machado-de-Avila R.A., Nguyen C., Molina F., et al. In vivo protection against Tityus serrulatus scorpion venom by antibodies raised against a discontinuous synthetic epitope. Vaccine 2010, 28:1168-1176.
21. Aubrey N., Muzard J., Juste M., Billiald P. Recombinant antibodies: towards a new generation of antivenoms?. J Soc Biol 2006, 200:345-354.
22. Espino-Solis G.P., Riaño-Umbarila L., Becerril B., Possani L.D. Antidotes against venomous animals: state of the art and prospectives. J Proteomics 2009, 72:183-199.
23. Zamudio F., Saavedra R., Martin B.M., Gurrola-Briones G., Hérion P., Possani L.D. Amino acid sequence and immunological characterization with monoclonal antibodies of two toxins from the venom of the scorpion Centruroides noxius Hoffmann. Eur J Biochem 1992, 204:281-292.
24. +-channels from the Colombian scorpion Tityus pachyurus. Biochim Biophys Acta 2006, 1764:76-84.
25. Batista C.V., Zamudio F.Z., Lucas S., Fox J.W., Frau A., Prestipino G., et al. Scorpion toxins from Tityus cambridgei that affect Na(+)-channels. Toxicon 2002, 5:557-562.
26. Marks J.D., Hoogenboom H.R., Bonnert T.P., McCafferty J., Griffiths A.D., Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 1991, 222:581-597.
27. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76:4350-4354.
28. Dixon W.J. The up-and-down method for small samples. JAMA 1965, 60:967-978.
29. de Bruin R., Spelt K., Mol J., Koes R., Quattrocchio F. Selection of high-affinity phage antibodies from phage display libraries. Nat Biotechnol 1999, 17:397-399.
30. Jacobin M.J., Robert R., Pouns O., Laroche-Traineau J., Nurden A., Peter K., et al. Improving selection of αIIbβ3-binding phage antibodies with increased reactivity derived from immunized donors. Clin Immunol 2003, 108:199-210.
31. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J Mol Biol 1990, 215:403-410.
32. Wörn A., Plückthun A. Stability engineering of antibody single-chain Fv fragments. J Mol Biol 2001, 305:989-1010.
33. Poon K.M., Tam F.C., Chui Y.L., Lim P.L. Single-chain Fv fragment lacks carrier specificity of the native antibody. Mol Immunol 2002, 39:19-24.
34. Jensen K.B., Larsen M., Pedersen J.S., Christensen P.A., Alvarez-Vallina L., Goletz S., et al. Functional improvement of antibody fragments using a novel phage coat protein III fusion system. Biochem Biophys Res Commun 2002, 298:566-573.
35. Goswami P., Saini D., Sinha S. Phage displayed scFv: pIII scaffold may fine tune binding specificity. Hybridoma (Larchmt) 2009, 28:327-331.
36. ®. Leukemia 2003, 17:260-266.
37. Davidkova G, Pettersson S., Holmberg D., Lundkvist I. Selective usage of VH genes in adult human B lymphocyte repertoires. Scand J Immunol 1997, 45:62-73.
38. Stollar B.D. The expressed heavy chain V gene repertoire of circulating B cells in normal adults. Ann N Y Acad Sci 1995, 29:265-274.
39. Riaño-Umbarila L., Contreras-Ferrat G., Olamendi-Portugal T., Morelos-Juárez C., Corzo G., Possani L.D., et al. Exploiting cross-reactivity to neutralize two different scorpion venoms with one single-chain antibody fragment. J Biol Chem 2011, 286:6143-6151.
40. Lira-da-Silva R.M., de AMORIM A.M., Kobler T. Envenomation by Tityus stigmurus (Scorpiones; Buthidae) in Bahia, Brazil. Rev Soc Bras Med Trop 2000, 33:239-245. [online].
41. Otero R., Navío E., Céspedes F.A., Núñez M.J., Lozano L., Moscoso E.R., et al. Scorpion envenoming in two regions of Colombia: clinical epidemiological and therapeutic aspects. Trans R Soc Trop Med Hyg 2004, 98:742-750.
42. Ministério da Saúde, Brasil. Manual of scorpions control, Série B. Textos Básicos de Saúde; 2009. Available from: [last accessed 31.03.11]. http://portal.saude.gov.br/portal/arquivos/pdf/manual_escorpioes_web.pdf.